Adolor, a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the management of opioid-related side effects and pain. Entereg, the company's lead product candidate, is a peripheral-acting opioid receptor antagonist designed for the management of gastrointestinal (GI) side effects related to opioid analgesics.

Report Highlights
Adolor, a development stage company operating in the US, specializes in the discovery and development of pain management products. Its lead candidate Entereg for postoperative ileus (POI) is in the final stage of FDA approval and is expected to be launched in 2008. The company recorded revenues of $15.1 million during the fiscal year ended December 2006, a decrease of 4% compared to 2005. The only contribution to revenue growth during 2002-2006 was license, collaboration and others. Adolor total revenues are forecasted to expand by a CAGR of 75% over the period 2006-2010. Entereg, the company's lead product, is expected to be launched in 2008. Revenues from Entereg are expected to record an absolute growth of $75 million from $38 million in 2008 to $75 million in 2010, which is approximately 97% over the 2006 performance.
[Studien Infos ausblenden]

Table 1: Adolor - Key Facts 6
Table 2: Adolor - Year-End Share Price and Market Capitalization, 2002-2006 ($) 10
Table 3: Adolor - Key Events Impacting Share Price Performance 11
Table 4: Adolor - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 12
Table 5: Adolor - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) 13
Table 6: Adolor - Balance Sheet, 2002-2006 ($ Mn) 14
Table 7: Adolor - Cash Flow, 2002-2006 ($ Mn) 14
Table 8: Adolor - In-house Pipeline Products 15
Table 9: Adolor - Collaboration Products 16
Table 10: Adolor - Forecast Sales, 2006-2010 ($ Mn) 17
Table 11: Adolor – Key Competitors 19
Table 12: Adolor - Key Suppliers 19
Table 13: Adolor- Key Shareholders 20
Table 14: Adolor - SWOT Analysis Summary 24
Table 15: Adolor - Value Chain Analysis 29
Table 16: Adolor - Scorecard 31
Table 17: Adolor - Key Employees 33
Table 18: Adolor - Financial and Operational Overview 42
Figure 1: Adolor - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 13

Figure 2: Adolor - Key Strategic Revenues, 2006-2010 ($ Mn) 18
[Tabellenverzeichnis ausblenden]